Tongling Jieya Biologic Technology's (SHE:301108) wholly-owned subsidiary Jieya Investment (Hainan) completed its deregistration after receiving a registration notice from the Hainan Provincial Administration for market regulation, according to a Wednesday filing with the Shanghai bourse.
Following the deregistration, Jieya Investment (Hainan) will no longer be included in Tongling Jieya Biologic Technology's consolidated financial statements, the filing said.